Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AcelRx Pharmaceuticals Inc (NASDAQ:ACRX)

2.55
Delayed Data
As of Apr 21
 -0.15 / -5.56%
Today’s Change
2.40
Today|||52-Week Range
4.08
-1.92%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues29.5M5.2M19.3M17.4M
 
 
 
 
 
Cost of Goods Sold0.00--778.0K10.3M
 
 
 
Depreciation And Amortization593.0K866.0K2.0M2.1M
 
 
 
 
 
 
Operating ExpensesGross Income28.9M--16.5M5.0M
 
 
 
 
General Expenses35.6M42.0M35.7M37.0M
 
 
 
 
 
Research And Development26.3M24.5M22.5M21.4M
 
 
 
 
 
Total Operating Expenses36.2M42.9M38.5M49.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-6.7M-37.6M-19.2M-32.0M
 
 
 
 
 
Extraordinary Credit0.007.6M2.1M600.0K
 
 
 
 
Extraordinary Charge-15.3M0.00-756.0K0.00
 
 
 
Interest Expense On Debt1.5M2.6M5.4M12.2M
 
 
 
 
 
Other Expenses32.0K-651.0K-380.0K318.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-23.4M-33.4M-23.6M-43.2M
 
 
 
 
 
Income Taxes0.000.00-760.0K-34.0K
 
 
 
Net Income-23.4M-33.4M-24.4M-43.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS39.7M43.4M44.3M45.3M
 
 
 
 
 
Shares To Calculate EPS Diluted39.7M44.3M44.5M45.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.59-$0.91-$0.60-$0.95
 
 
 
 
 
EPS Diluted-$0.59-$0.91-$0.60-$0.95